Alberta opens second age bracket for AstraZenica COVID-19 vaccine appointments - Global News | Canada News Media
Connect with us

Business

Alberta opens second age bracket for AstraZenica COVID-19 vaccine appointments – Global News

Published

 on


Another age bracket of Albertans will be able to book appointments for the AstraZenica COVID-19 vaccine starting Thursday, after more than 11,500 bookings were made Wednesday.

According to Dr. Deena Hinshaw, Albertans who were born in 1958, as well as First Nations, Metis and Inuit people born in 1973, will be eligible for an AztraZenica immunization.

Read more:
All eyes on Alberta COVID-19 vaccine booking system Wednesday for AstraZeneca

The province is rolling out eligibility for its current 58,000 doses of the third vaccine to be approved in Canada based on birth year.

“If you are eligible to get the vaccine, please do so. And encourage your friends and neighbours to do so as well. The more people who become immunized, the less the virus will be able to mutate, and the less it will impact our communities.”

Story continues below advertisement

Those eligible are encouraged to book online or book in off-peak times, as 811 demand and call volume is expected to be high.






3:13
Senior Toronto scientists question 4-month delay of 2nd dose


Senior Toronto scientists question 4-month delay of 2nd dose

Hinshaw said as of Wednesday, nearly 138,000 seniors over the age of 75 who are not living in designated supported living or continuing care facilities – which were included in Phase 1A of Alberta’s vaccine rollout – have either gotten their shot or have their appointment booked.

So far, 309,000 doses of vaccine have been administered to Albertans, with 91,000 people being fully immunized against COVID-19 with two doses.

Hinshaw said it “can be tempting to let your guard down after immunization,” but stressed that more research needs to be done before health officials can determine how being vaccinated impacts viral transmission.

“Even if you have been vaccinated with one or two doses, all public health orders in place still apply,” she said.

Story continues below advertisement

Hinshaw stressed that while it’s recommended those with chronic health issues try to get a Pfizer or Moderna vaccine rather than AstraZenica, the AstraZeniva vaccine is “not unsafe” for those who suffer from chronic conditions.

“If an individual who has a chronic condition wishes to receive AstraZenica and they’re in the appropriate age group, they could choose to do so,” she said.

“There is no requirement to prove that an individual is healthy if they wish to receive AstraZenica vaccine and they are in the eligible age group.”

Those looking to book an AstraZenica vaccine appointment are encouraged to weigh their options and make the best decision for them, Hinshaw said.






0:38
AstraZeneca’s COVID-19 vaccine ‘not unsafe’ for chronic conditions: Hinshaw


AstraZeneca’s COVID-19 vaccine ‘not unsafe’ for chronic conditions: Hinshaw

Bookings for Phase 2A of the vaccine rollout is scheduled to start Monday, March 15, and will be open to those 65 to 74, no matter where they live, as well as First Nations, Metis and Inuit people 50 and older. Staff and residents of licensed supportive livings are also included.

Story continues below advertisement

However, Global News called 10 pharmacies in Edmonton currently providing immunizations, and several were already scheduling Phase 2A appointments. Hinshaw said some pharmacies have already started taking those appointments because they have stores of Pfizer vaccine that could be set to expire soon.

“We have also indicated to pharmacies that if they have doses of vaccine (that) will be expiring, that they should using those so that we don’t waste that produce,” she said.

“And so there may be pharmacies that have appointments open that haven’t been taken by those 75 plus, and then they would naturally go on to that next eligible category in order to not waste the vaccine.”

Alberta Health later said in an email that while pharmacies are taking those bookings, people are being asked to “be patient” and wait until Monday.

Read more:
Alberta COVID-19 vaccine booking site experiences ‘very high volumes’ as appointments open to those 75 and older

Hinshaw said the province is still working through the expression of interest process of getting doctors’ offices and clinics added to the list of places where vaccines can be administered. She said pharmacies have been the dominant provider of flu vaccines in Alberta, which means they already have the infrastructure in place for storage and tracking of vaccines that few clinics currently have.

Read more:
AstraZeneca’s COVID-19 vaccine not recommended for people in Canada over age 65: NACI

Story continues below advertisement

Hinshaw said roughly half the current supply of AstraZenica vaccine has to be used up before April 2, with the remainder having a longer shelf life.

With the current uptake in appointments, she doesn’t forsee any issue with having those vaccines in Albertans’ arms before their expiry date.

“With respect to whether Albertans might be waiting for an mRNA vaccine — the Pfzer or the Moderna – it’s difficult to say. I do think that we have good evidence, certainly real-world evidence out of the U.K., that the AstraZenica vaccine is effective at preventing severe outcomes in the individual who receives it,” Hinshaw said.

“So I would encourage Albertans who are eligible for vaccine to look at the options and then choose the vaccine that they’re able to get as soon as they can.”

16-week gap between shots

Starting Wednesday, appointments for first and second COVID-19 vaccine doses in Alberta will be spaced up to 16 weeks apart, but one infectious diseases researcher said that may not always be the case.

The change in timing comes after a recommendation from the National Advisory Committee on Immunization (NACI), which cited evidence showing there was some protection against severe outcomes after the first dose.

Read more:
Provinces, territories can wait 4 months to administer 2nd COVID-19 shot, NACI says

Story continues below advertisement

Up until Wednesday, doses were being spaced out up to six weeks in Alberta, which is already more than the two- and three-week recommendations of manufacturers Pfizer and Moderna.
However, it is not clear how long the province may follow the NACI recommendation of up to 16 weeks.

“It’s certainly possible that the door has been left open to be able to revert back to the timelines that were on the box, on the label, and that we have more data for,” said Dr. Ilan Schwartz, an infectious diseases researcher at the University of Alberta.

“That said, from the standpoint of getting as many people as quickly as possible, it does make sense to hold off on those first doses initially, based on the data that has emerged. But I think as supply ramps up and starts to catch up with demand, I think certainly there could be a situation where that recommendation is relaxed.”

Read more:
Alberta considers further extending time between doses of COVID-19 vaccine

Schwartz said it may be possible to see large windows where people can select their date for a follow-up appointment.

Case numbers

Alberta labs confirmed an additional 399 new COVID-19 infections over the last 24 hours, from roughly 10,400 tests, putting the province’s positivity rate at 3.7 per cent.

Story continues below advertisement

A total of 254 people were being treated in the province’s hospitals, with 37 of them in intensive care units.

Two deaths were reported on Wednesday.

A woman in her 70s in the Calgary zone with no known comorbidities died. A woman in her 80s in the Central zone also died. Her case included comorbidities, according to Alberta Health.






1:56
Alberta identifies 47 COVID-19 variant cases Wednesday


Alberta identifies 47 COVID-19 variant cases Wednesday

Forty-seven new cases of variants of concern were also detected in the province, bringing the total number of cases since Dec. 15 to 734.

Hinshaw said the percentage of variant cases in Alberta’s total case numbers has risen slightly in six weeks, from three per cent in late January to nine per cent currently – which is significantly lower than other jurisdictions, which have seen their cases rise from three to four per cent to nearly 50 per cent in the same time frame.

Story continues below advertisement

“This means that our health measures — both the overall restrictions, as well as the targeted measures for variant cases – are working to slow the growth. And if we continue to work together, we can continue to limit the spread.”

[embedded content]

Advertisement

© 2021 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Japan’s SoftBank returns to profit after gains at Vision Fund and other investments

Published

 on

 

TOKYO (AP) — Japanese technology group SoftBank swung back to profitability in the July-September quarter, boosted by positive results in its Vision Fund investments.

Tokyo-based SoftBank Group Corp. reported Tuesday a fiscal second quarter profit of nearly 1.18 trillion yen ($7.7 billion), compared with a 931 billion yen loss in the year-earlier period.

Quarterly sales edged up about 6% to nearly 1.77 trillion yen ($11.5 billion).

SoftBank credited income from royalties and licensing related to its holdings in Arm, a computer chip-designing company, whose business spans smartphones, data centers, networking equipment, automotive, consumer electronic devices, and AI applications.

The results were also helped by the absence of losses related to SoftBank’s investment in office-space sharing venture WeWork, which hit the previous fiscal year.

WeWork, which filed for Chapter 11 bankruptcy protection in 2023, emerged from Chapter 11 in June.

SoftBank has benefitted in recent months from rising share prices in some investment, such as U.S.-based e-commerce company Coupang, Chinese mobility provider DiDi Global and Bytedance, the Chinese developer of TikTok.

SoftBank’s financial results tend to swing wildly, partly because of its sprawling investment portfolio that includes search engine Yahoo, Chinese retailer Alibaba, and artificial intelligence company Nvidia.

SoftBank makes investments in a variety of companies that it groups together in a series of Vision Funds.

The company’s founder, Masayoshi Son, is a pioneer in technology investment in Japan. SoftBank Group does not give earnings forecasts.

___

Yuri Kageyama is on X:

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Trump campaign promises unlikely to harm entrepreneurship: Shopify CFO

Published

 on

 

Shopify Inc. executives brushed off concerns that incoming U.S. President Donald Trump will be a major detriment to many of the company’s merchants.

“There’s nothing in what we’ve heard from Trump, nor would there have been anything from (Democratic candidate) Kamala (Harris), which we think impacts the overall state of new business formation and entrepreneurship,” Shopify’s chief financial officer Jeff Hoffmeister told analysts on a call Tuesday.

“We still feel really good about all the merchants out there, all the entrepreneurs that want to start new businesses and that’s obviously not going to change with the administration.”

Hoffmeister’s comments come a week after Trump, a Republican businessman, trounced Harris in an election that will soon return him to the Oval Office.

On the campaign trail, he threatened to impose tariffs of 60 per cent on imports from China and roughly 10 per cent to 20 per cent on goods from all other countries.

If the president-elect makes good on the promise, many worry the cost of operating will soar for companies, including customers of Shopify, which sells e-commerce software to small businesses but also brands as big as Kylie Cosmetics and Victoria’s Secret.

These merchants may feel they have no choice but to pass on the increases to customers, perhaps sparking more inflation.

If Trump’s tariffs do come to fruition, Shopify’s president Harley Finkelstein pointed out China is “not a huge area” for Shopify.

However, “we can’t anticipate what every presidential administration is going to do,” he cautioned.

He likened the uncertainty facing the business community to the COVID-19 pandemic where Shopify had to help companies migrate online.

“Our job is no matter what comes the way of our merchants, we provide them with tools and service and support for them to navigate it really well,” he said.

Finkelstein was questioned about the forthcoming U.S. leadership change on a call meant to delve into Shopify’s latest earnings, which sent shares soaring 27 per cent to $158.63 shortly after Tuesday’s market open.

The Ottawa-based company, which keeps its books in U.S. dollars, reported US$828 million in net income for its third quarter, up from US$718 million in the same quarter last year, as its revenue rose 26 per cent.

Revenue for the period ended Sept. 30 totalled US$2.16 billion, up from US$1.71 billion a year earlier.

Subscription solutions revenue reached US$610 million, up from US$486 million in the same quarter last year.

Merchant solutions revenue amounted to US$1.55 billion, up from US$1.23 billion.

Shopify’s net income excluding the impact of equity investments totalled US$344 million for the quarter, up from US$173 million in the same quarter last year.

Daniel Chan, a TD Cowen analyst, said the results show Shopify has a leadership position in the e-commerce world and “a continued ability to gain market share.”

In its outlook for its fourth quarter of 2024, the company said it expects revenue to grow at a mid-to-high-twenties percentage rate on a year-over-year basis.

“Q4 guidance suggests Shopify will finish the year strong, with better-than-expected revenue growth and operating margin,” Chan pointed out in a note to investors.

This report by The Canadian Press was first published Nov. 12, 2024.

Companies in this story: (TSX:SHOP)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

RioCan cuts nearly 10 per cent staff in efficiency push as condo market slows

Published

 on

 

TORONTO – RioCan Real Estate Investment Trust says it has cut almost 10 per cent of its staff as it deals with a slowdown in the condo market and overall pushes for greater efficiency.

The company says the cuts, which amount to around 60 employees based on its last annual filing, will mean about $9 million in restructuring charges and should translate to about $8 million in annualized cash savings.

The job cuts come as RioCan and others scale back condo development plans as the market softens, but chief executive Jonathan Gitlin says the reductions were from a companywide efficiency effort.

RioCan says it doesn’t plan to start any new construction of mixed-use properties this year and well into 2025 as it adjusts to the shifting market demand.

The company reported a net income of $96.9 million in the third quarter, up from a loss of $73.5 million last year, as it saw a $159 million boost from a favourable change in the fair value of investment properties.

RioCan reported what it says is a record-breaking 97.8 per cent occupancy rate in the quarter including retail committed occupancy of 98.6 per cent.

This report by The Canadian Press was first published Nov. 12, 2024.

Companies in this story: (TSX:REI.UN)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version